Swiss dental company vVARDIS secures new investment to expand Curodont rollout

2025-07-21

ZUG, Switzerland: Swiss manufacturer vVARDIS has raised an additional US$50 million (€43 million*) in funding from global healthcare investor OrbiMed, bringing the total capital secured to US$85 million.

vVARDIS secures $35m for dental treatment expansion

2025-02-12

(Image: vVARDIS) vVARDIS and OrbiMed have announced the closing of a $35m financing. The capital will support the former’s growth initiatives and global commercial expansion.